Hostname: page-component-586b7cd67f-t7czq Total loading time: 0 Render date: 2024-11-22T08:31:22.836Z Has data issue: false hasContentIssue false
  • English
  • Français

Re-evaluating carbamazepine prophylaxis in bipolar disorder

Published online by Cambridge University Press:  03 January 2018

Robert M. Post ,
Kirk D. Denicoff ,
Mark A. Frye  and
Gabriele S. Leverich
Robert M. Post*
Affiliation:
Biological Psychiatry Branch, National Institute of Mental Health, Bethesda, Maryland, USA
Kirk D. Denicoff
Affiliation:
Biological Psychiatry Branch, National Institute of Mental Health, Bethesda, Maryland, USA
Mark A. Frye
Affiliation:
Biological Psychiatry Branch, National Institute of Mental Health, Bethesda, Maryland, USA
Gabriele S. Leverich
Affiliation:
Biological Psychiatry Branch, National Institute of Mental Health, Bethesda, Maryland, USA
*
Dr Robert M. Post, Chief, Biological Psychiatry Branch, NIMH, Building 10, Room 3N212, 10 Center Drive, MSC 1272, Bethesda, MD 20892-1272, USA
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Editorials
Information
The British Journal of Psychiatry , Volume 170 , Issue 3 , March 1997 , pp. 202 - 204
Copyright
Copyright © 1997 The Royal College of Psychiatrists 

References

Ballenger, J. C. & Post, R. M. (1978) Therapeutic effects of carbamazepine in affective illness: A preliminary report. Communications in Psychopharmacology. 2, 159–175.Google Scholar
Bellaire, W., Demisch, K. & Stoll, K.-D. (1990) Carbamazepine vs. lithium. Application m the prophylaxis of recurrent affective and schizoaffective psychoses. Munch Med Wschr. 132. S82–S86.Google Scholar
Bowden, C. L., Brugger, A. M., Swann, A. C., et al (1994) Efficacy of divalproex vs lithium and placebo in the treatment of mania. Journol of the American Medical Association. 271, 918–924.CrossRefGoogle ScholarPubMed
Calabrese, J. R., Woyshville, M. J., Kimmel, S. E., et al (1993) Predictors of valproate response m bipolar rapid cycling. Journal of Clinical Psychopharmacology, 13, 280–283.Google Scholar
Cabera, J. F., Muhlbauar, H. D., Schley, J., et al (1986) Long-term randomized clinical trial on oxcarbazepme vs. lithium in bipolar and schizoaffective disorders: preliminary results. Pharmacopsychiatry 19, 282–283.CrossRefGoogle Scholar
Dardennes, R., Even, C., Bange, F., et al (1995) Comparison of carbamazepine and lithium in the prophylaxis of bipolar disorders. A meta-analysis. British Journal of Psychiatry. 166. 378 381.CrossRefGoogle ScholarPubMed
Denicoff, K. D., Blalce, K. D., Smith-Jackson, E. E., et al (1994) Morbidity in treated bipolar disorder: a one-year prospective study using daily life chart ratings. Depression. 2. 95 104.Google Scholar
Di Cosunzo, E. & Schifano, F. (1991) Lithiunrt alone or in combination with carbamazepine for the treatment of rapid-cycling bipolar affective disorder Acta Psychiotnca Scandinavica. 83. 456–459.Google Scholar
Elphick, M., Lyons, F. & Cowen, P. J. (1988) Low tolerability of carbamazepine in psychiatric patients may restrict its clinical usefulness. Journal of Psychopharmacology. 2, 1–4.Google Scholar
Emrich, H. M., Von Zerssen, D., Kissling, W., et al (1980) Effect of sodium valproate m mama. The GABA hypothesis of affective disorders. Arch Psychiatr Nervenkr, 229, 1–16.CrossRefGoogle Scholar
Grof, P. (1994) Designing long-term clinical trials in affective disorders. Journol of Affective Disorders. 30, 243–255.Google Scholar
Hirschfeld, R. M. A., Clayton, R. Cohen, I., et al (1994) American Psychiatric Association practice guidelines for bipolar disorder. American Journal of Psychiatry. 151 (suppl.), 1–36.Google Scholar
Jacobsen, F. M. (1993) Low-dose valproate; A new treatment for cyclothymia, mild rapid cycling disorders, and premenstrual syndrome, journal of Clinical Psychiatry. 54, 229–234.Google ScholarPubMed
Ketter, T. A., Kimbrell, T. A., George, M. S., et al (1996) Baseline hypermetabolism may predict carbamazepine response, and hypometabolism nimodipine response m mood disorders. Abstracts of the 20th CINP Congress. 10 (abstract 0–5–6).Google Scholar
Kishimoto, A. & Okuma, T. (1986) Antimamc and prophylactic effects of carbamazepine in affective disorders. In Biological Psychiatry (eds Shagas, C. Josiassen, R. C., Bridger, W. H. et al). pp. 883–885. Amsterdam: Elsevier.Google Scholar
Lambert, P. A. (1984) Acute and prophylactic therapies of patients with affective disorders using valpromide (dipropylacetamide). In Anticonvulsants in Affective Disorders (eds Emnch, H. M. Okuma, T. & Muller, A. A.), pp. 33–44, Amsterdam: Exerpta Medica.Google Scholar
Lusznat, R. M., Murphy, D. R A. Nunn, C. M. H. (1988) Carbamazepine vs. lithium in the treatment and prophylaxis of mama. British Journal of Psychiatry 153, 198–204.Google Scholar
McElroy, S. L., Keck, P. E., Pope, H. G., et al (1992) Valproate m the treatment of bipolar disorder: Literature review and clinical guidelines. Journal of Clinical Psychopharmacology 12 (suppl. I), 42S–52S.Google Scholar
Mosolov, S. N. (1991) Comparative effectiveness of preventive use of lithium carbonate, carbamazepine and sodium valproate in affective and schizoaffective psychoses. Zhurnal Nevropatologii I Psikhiatni Imeni S S. Korsakova (Moskva). 91, 78–83.Google ScholarPubMed
Murphy, D. J., Gannon, M. A. & McGennis, A. (1989) Carbamazepine in bipolar affective disorder (letter). Lancet. ii 1151 1152.Google Scholar
O'Connell, R. A., Major, J. A., Flattew, L., et al (1991) Outcome of bipolar disorder on long-term treatment with lithium. British Journal of Psychiatry 159, 123–129.Google Scholar
Okuma, T., Inanaga, K., Otsuke, S., et al (1981) A preliminary double-blind study of the efficacy of carbamazepine in prophylaxis of manic-depressive illness. Psychopharmacology 73, 95–96.Google Scholar
Pellock, J. M. (1987) Carbamazepine side effects in children and adults. Epilepsia. 28 (suppl. 3), S64–S70.Google Scholar
Placidi, G. F., Lenzi, A., Lazzerini, F., et al (1986) The comparative efficacy and safety of carbamazepine versus lithium: A randomized, double-blind 3-year trial in 83 patients. Journal of Clinical Psychiatry 47, 490–494.Google Scholar
Post, R. M., Uhde, T. W., Ballenger, J. C., et al (1983) Prophylactic efficacy of carbamazepine in manic-depressive illness. American Journal of Psychiatry 140, 1602–1604.Google Scholar
Post, R. M., Ballenger, J. C., Berrettlni, W. H., Uhde, T. W., et al (1984) Selective response to the anticonvulsant carbamazepine in manic-depressive illness: A case study Journal of Clinical Psychopharmacology 4, 178–185.Google Scholar
Post, R. M., Ballenger, J. C., Berrettlni, W. H., Uhde, T. W., Leverich, G. S., Rosoff, A. S., et al (1990) Carbamazepine prophylaxis in refractory affective disorders: A focus on long-term follow-up. Journol of Clinical Psychopharmacology 10, 318–327.Google Scholar
Post, R. M., Ballenger, J. C., Berrettlni, W. H., Uhde, T. W., Leverich, G. S., Rosoff, A. S., Ketter, T. A., Pazzaglla, P. J., et al (1996) Rational polypharmacy in the bipolar affective disorders. Epilepsy Research, in press.Google Scholar
Prien, R. F. & Gelenberg, A. J. (1989) Alternatives to lithium for preventive treatment of bipolar disorder. American Journal of Psychiatry 146, 840–848.Google Scholar
Schaff, M. R., Fawcett, J. & Zajecka, J. M. (1993) Divalproex sodium in the treatment of refractory affective disorders. Journal of Clinical Psychiatry 54, 380–384.Google Scholar
Svetska, J., Nahunek, K., Ceskova, E., et al (1985) Carbamazepine prophylaxis of affective psychoses (intraindividual comparison with lithium carbonate). Activ Nerv Sup. 27, 261–262.Google Scholar
Vestergaard, P. (1992) Treatment and prevention of mama: A Scandinavian perspective. Neuropsychopharmacology 7, 249–260.Google Scholar
Watkins, S. E., Callender, K., Thomas, D. R., et al (1987) The effect of carbamazepine and lithium on remission from affective illness. British Journal of Psychiatry 150, 180–182.CrossRefGoogle ScholarPubMed
Submit a response

eLetters

No eLetters have been published for this article.